How Japan’s medtech leaders can use M&A to create a competitive advantage

Companies that invest inorganically during a downturn generally emerge stronger than their competitors. Japanese medtech companies have the cash, the incentive, and the opportunity to do just that.
How Japan’s medtech leaders can use M&A to create a competitive advantage